secwatch.observer — SEC 8-K summary
======================================

Issuer:     Krystal Biotech, Inc. (KRYS)
CIK:        0001711279
Form:       8-K
Filed at:   2023-05-23T23:59:59+00:00
Accession:  0001711279-23-000044
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Krystal Biotech stockholders elect three Class III directors at 2023 annual meeting
--------------------------------------------------------------------------------

- Krish S. Krishnan, Kirti Ganorkar, and Christopher Mason elected as Class III directors for three-year terms.
- Ratification of KPMG as independent auditor for FY2023 approved (22,098,460 for, 2,547 against).
- Advisory vote on named executive officer compensation approved (18,759,786 for, 907,235 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711279/000171127923000044/0001711279-23-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711279/000171127923000044/krys-20230523.htm
  HTML page:      https://secwatch.observer/filing/0001711279-23-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer